XM does not provide services to residents of the United States of America.

UK Stocks-Factors to watch on Dec 20



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-UK Stocks-Factors to watch on Dec 20</title></head><body>

Adds new items, updates futures

Dec 20 (Reuters) -Britain's FTSE 100 .FTSE index is seen opening lower on Friday, with futures FFIc1 down 0.06%.


* GSK: GSKGSK.L said the addition of its cancer drugJemperli to both standard of care chemotherapy and Zejula maintenance improved survival in patients with advanced ovarian cancer without the disease getting worse in a late-stage trial.

* RETAIL SALES: British retail salesrose by a weaker-than-expected 0.2% in November, according to figures from the Office for National Statistics which added to signs of slow momentum in the economy.

* BUDGET: Britain ran a smaller-than-expected budget deficit last month but only because past falls in inflation pushed down interest paid on government bonds, a limited boost for finance minister Rachel Reeves following her budget announcement.

* HSBC: HSBCHSBA.L Chairman Mark Tucker willlead the British government's most important business delegation to China since 2018 next month, sources told Reuters, as Chancellor Rachel Reeves seeks to attract greater Chinese investment into Britain.

* BP: British oil major BP BP.L on Thursday said it has reached a deal with the Iraqi government on the technical terms to redevelop the Kirkuk oil and gas fields.

* UK CAR PRODUCTION: UK car manufacturing hit its lowest November output since 1980, as the industry grapples with the shift to zero-emission vehicles and rising costs, according to data by the Society of Motor Manufacturers and Traders.

* OIL: Oil prices fell on worries about demand growth in 2025, especially in top crude importer China, putting global oil benchmarks on track to end the week down nearly 3%.

* GOLD: Gold prices were set for a weekly decline.


* For more on the factors affecting European stocks, please click on: LIVE/

TODAY'S UK PAPERS

> Financial Times PRESS/FT

> Other business headlines PRESS/GB



($1 = 0.7997 pounds)



Reporting by Aby Jose Koilparambil and DhanushVignesh Babu in Bengaluru

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.